Aarti Drugs Ltd Share Price
(AARTIDRUGS)
₹353.15▲0.67%
as on 11:17AM, 30 Apr 2025
Aarti Drugs Ltd Performance
Day's Low
Day's High
₹349Day's Price Range₹361.952 Week's Low
52 Week's High
₹31252-Week Price Range₹635
| Returns % | |
| 1 Month Return | + 2.24 % |
| 3 Month Return | -14.01 % |
| 1 Year Return | -30.47 % |
| Market Stats | |
| Previous Close | ₹350.80 |
| Open | ₹353.15 |
| Volume | 1.27L |
| Upper Circuit | ₹420.95 |
| Lower Circuit | ₹280.65 |
| Market Cap | ₹3,225.08Cr |
Aarti Drugs Ltd Fundamentals
P/E Ratio
21.06
PEG Ratio
-7.34
Market Cap
₹3,225.08 Cr
P/B Ratio
3.39
EPS
18.66
Dividend Yield
0.23
Sector
Pharmaceuticals
ROE
12.39
Mutual Fund Holdings of Aarti Drugs Ltd
Aarti Drugs Ltd Analyst Rating
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for Aarti Drugs Ltd. An average target of ₹465
Source: S&P Global Market Intelligence
Aarti Drugs Ltd Share analysis
Aarti Drugs Ltd price forecast by 1 analysts
Upside of32.55%
High
₹465
Target
₹465.00
Low
₹465
Aarti Drugs Ltd target price ₹465, a slight upside of 32.55% compared to current price of ₹353.15. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Aarti Drugs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:20.45%
Forecast
Actual
Including amortisation and stock based compensations
Aarti Drugs Ltd EPS growth forecast
EPS estimate Q1, FY2027:52.82%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Aarti Drugs Ltd
Aarti Drugs Shares Hit 52-Week Low - 13 Mar, 2025
Aarti Drugs Ltd shares fell 2.2% to a 52-week low of ₹332.60, marking a 9% decline over five sessions and 26% over the past year. Despite a modest 1.1% increase in net profit to ₹37.1 crore for Q4 2024, revenue dropped 8.1% year-over-year to ₹556.6 crore.Aarti Drugs Warned by SEBI for Insider Trading - 07 Mar, 2025
Aarti Drugs Ltd has received an administrative warning letter from SEBI for violations related to insider trading regulations, raising concerns about compliance.Aarti Drugs Cleared by US FDA for Exports - 14 Feb, 2025
Aarti Drugs Limited has been removed from the US FDA Import Alert 66-40, allowing the company to resume exports to the US market. This follows successful inspections and satisfactory responses to FDA concerns. The clearance enables Aarti to export key pharmaceutical products without restrictions, marking a significant boost for the company.
Insights on Aarti Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 33.24 Cr → 37.05 Cr (in ₹), with an average increase of 5.3% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 7.78% to 8.75% in Mar 2025 quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 55.38% to 55.48% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 81.7%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 160.8%
NEGATIVE IMPACTPrice Dip
In the last 3 years, AARTIDRUGS stock has moved down by -23.8%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 33.57% to 32.57% in Mar 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 2.28% to 2.25% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 599.81 Cr → 568.5 Cr (in ₹), with an average decrease of 5.2% per quarter
Aarti Drugs Ltd Financials
Aarti Drugs Ltd Index Inclusions
Aarti Drugs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 55.48% | 0.00 | |
| Foreign Institutions | 2.25% | 0.00 | |
| Mutual Funds | 8.75% | 0.00 | |
| Retail Investors | 32.57% | 0.00 | |
| Others | 0.95% | 0.00 |
Aarti Drugs Ltd Key Indicators
Aarti Drugs Ltd Valuation
Aarti Drugs Ltd in the last 5 years
Lowest (8.29x)
March 31, 2020
Today (21.06x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (57.24x)
August 24, 2020
Aarti Drugs Ltd Earnings and Dividends
Aarti Drugs Ltd Earnings Results
Aarti Drugs Ltd’s net profit jumped 1.04% since last year same period to ₹37.05Cr in the Q3 2024-2025. On a quarterly growth basis, Aarti Drugs Ltd has generated 5.83% jump in its net profits since last 3-months.
Read More about Earnings ResultsAarti Drugs Ltd Dividends January,2025
In the quarter ending December 2024, Aarti Drugs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.29%.
Read More about Dividends
Aarti Drugs Ltd Technicals Summary
Bearish
Neutral
Bullish
Aarti Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Aarti Drugs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹3,225.08 Cr | 19.24% | 0.64 | ₹171 Cr | ₹2,528 Cr | |
| BUY | ₹28,928.76 Cr | 133.26% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹14,252.57 Cr | 31.52% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹4,817.52 Cr | 2.55% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹13,783.61 Cr | 40.3% | 0.68 | ₹218 Cr | ₹1,296 Cr |
About Aarti Drugs Ltd
Revenue: ₹556.60Cr as on December 2024 (Q4 24)
Net Profit: ₹37.09Cr as on December 2024 (Q4 24)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
| Organisation | Aarti Drugs Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Aarti Drugs Ltd
What is Aarti Drugs Ltd price today?
Aarti Drugs Ltd share price today stands at ₹353.15, Open: ₹353.15, Previous Close: ₹350.8, High: ₹361.9, Low: ₹349, 52 Week High: ₹635, 52 Week Low: ₹312.
How to Buy Aarti Drugs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Aarti Drugs Ltd shares
What are today's traded volumes of Aarti Drugs Ltd?
Today's traded volume of Aarti Drugs Ltd(AARTIDRUGS) is 1.27L.
What is today's market capitalisation of Aarti Drugs Ltd?
Today's market capitalisation of Aarti Drugs Ltd(AARTIDRUGS) is ₹3225.08Cr.
What is the 52 Week High and Low Range of Aarti Drugs Ltd?
How much percentage Aarti Drugs Ltd is down from its 52 Week High?
Aarti Drugs Ltd (AARTIDRUGS) share price is ₹353.15. It is down -44.39% from its 52 Week High price of ₹635
How much percentage Aarti Drugs Ltd is up from its 52 Week low?
Aarti Drugs Ltd (AARTIDRUGS) share price is ₹353.15. It is up 13.19% from its 52 Week Low price of ₹312